Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 601.7777 ↓ -0.07%
[as on 16 June, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option and its peers as on 16 June, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option 5.67% -0.07% -0.09% -1.58% 7.73% 4.79% 21.61% 13.5% 22.17% 16.21%
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -7.04% 0.14% 2.46% -0.4% 5.23% -6.27% 8.6% 14.02% 15.37% 14.89%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -4.4% 0.46% 3.16% 3.43% 6.82% -0.62% 11.11% 10.73% 12.59% 12.73%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 12.03% -0.55% 0.9% 1.87% 12.8% 11.21% 25.19% 16.73% 24.52% 14.54%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 2.67% 0.72% 1.75% 0.68% 12.08% 3.47% 18.27% 19.3% 18.87% 16.22%
SBI PSU Fund - DIRECT PLAN - GROWTH 2.88% -0.15% 0.43% -0.64% 2.03% 9.51% 29.34% 24.15% 19.73% 15.91%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns -9.42% 8.09% 4.71% 2.97% 68.53% 23.84% -9.16% 41.33% 35.46% -2.94%

Discrete returns (monthly)

MonthAug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026
Returns -1.41% -2.52% 2.24% 0.9% -1.24% -4.66% 5.31% -4.85% 6.03% 2.37%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 13.46% 2.57%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.45% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.55%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology13.92%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology8.45%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology6.41%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology5.96%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology5.42%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.15%
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing3.86%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology3.36%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services3.24%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services3.15%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology3.15%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology2.87%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology2.81%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology2.77%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology2.64%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.43%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.17%
JB Chemicals & Pharmaceuticals LimitedJBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology2.09%
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services2.02%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services1.94%
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.90%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology1.72%
Narayana Hrudayalaya LimitedNH (INE410P01011)Healthcare Services1.67%
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology1.51%
Sanofi Consumer Healthcare India LimitedSANOFICONR (INE0UOS01011)Pharmaceuticals & Biotechnology1.16%
Suraksha Diagnostic LimitedSURAKSHA (INE877V01027)Healthcare Services1.12%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services1.11%
Sanofi India LimitedSANOFI (INE058A01010)Pharmaceuticals & Biotechnology0.94%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.93%
Akums Drugs and Pharmaceuticals LimitedAKUMS (INE09XN01023)Pharmaceuticals & Biotechnology0.89%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology0.88%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.67%
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology0.62%
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology0.38%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology0.14%
Portfolio data is as on date 31 March, 2026

NAV history

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
16 June, 2026601.7777 -0.07%
15 June, 2026602.1912 -0.42%
12 June, 2026604.7016 0.5%
11 June, 2026601.6791 0.21%
10 June, 2026600.4294 -0.31%
9 June, 2026602.3193 0.56%
8 June, 2026598.9374 -0.04%
5 June, 2026599.1954 0.53%
4 June, 2026596.0213 0.11%
3 June, 2026595.3609 0.35%
2 June, 2026593.2803 -0.07%
1 June, 2026593.7091 -0.8%
29 May, 2026598.5008 -1.2%
27 May, 2026605.7562 -0.04%
26 May, 2026606.0050 -0.33%
25 May, 2026608.0001 0.16%
22 May, 2026607.0458 -1.52%
21 May, 2026616.3936 0.42%
20 May, 2026613.8400 -0.3%
19 May, 2026615.6743 0.42%
18 May, 2026613.0786 0.26%
15 May, 2026611.4619 0.42%
14 May, 2026608.8834 2.03%
13 May, 2026596.7510 0.23%
12 May, 2026595.4100 -1.46%
11 May, 2026604.2489 0.14%
8 May, 2026603.3925 0.28%
7 May, 2026601.7027 0.37%
6 May, 2026599.4765 2.2%
5 May, 2026586.5475

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The latest NAV of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option is 601.7777 as on 16 June, 2026.
  • What are YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 5.67% as on 16 June, 2026.
  • What are 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 4.79% as on 16 June, 2026.
  • What are 3 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 21.61% as on 16 June, 2026.
  • What are 5 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 13.5% as on 16 June, 2026.
  • What are 10 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 13.5% as on 16 June, 2026.